uMotif nominated by Journal of mHealth in the ‘Global Digital Health 100’
We’ve been nominated by the Journal of mHeath as part of the 2017 ‘Global Digital Health 100’. This annual list of the leading technology companies recognises those who have the greatest potential to lead innovation.
We’re delighted to have been nominated in a year that’s seen us publish results of our highly successful NHS Parkinson’s Study in npj Parkinson’s Disease journal, publish results of the exciting Cloudy study with Manchester University in JMIR, close new deals with a range of major pharma companies including AstraZeneca, and significantly growing the fantastic uMotif team.
We’re looking forward to continued growth, innovation and patient-centred impact in 2018 and beyond!
Press release on the awards follows.
Announcing the 2017 Global Digital Health 100
London, United Kingdom – 20 December 2017
The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.
Over the past four years, the Global Digital Health 100 has become established as the international benchmark of innovation in the healthcare technology industry.
This year’s 100 sees many new entrants from all sides of the HealthTech spectrum, from new innovators looking to apply technologies like blockchain and AI to healthcare, to solution providers who are demonstrating rapid growth in more established tech-led services like teleheath.
Competition for the 2017 list has been fierce, with more nominations than in any previous year and hundreds of companies analysed and assessed to determine which solutions made the final cut
From across the Health Continuum
The diversity of this year’s list stands out immediately. With innovations targeting just about every corner of healthcare the honouree companies offer technologies across a range of categories including, clinical solutions, wearable technologies, healthcare applications, medical devices, virtual reality and data analytics. These are all solutions and services that are transforming, or have the potential to transform, and disrupt the way in which healthcare is delivered.
The list also provides insight into the key sector trends that we are beginning to see emerge from across the healthcare continuum when it comes to the adoption of technology-led products and services.
Digital Health is Maturing
Reflecting the ever-growing importance of mobile, digital and connected solutions in the healthcare industry, the Global Digital Health 100-2017 recognises the significant work being carried out by organisations from around the globe.
While many companies, over the past few years, have failed despite having truly innovative technologies to offer, the 2017 cohort shows that it is essential to not only demonstrate innovation in technology, but also innovation in service and business model development as a requisite to succeeding as a technology company in the healthcare industry.
Identifying the 100
The Global Digital Health 100 represents 6 months of analysis by the editorial and advisory team at The Journal of mHealth, who considered the offerings and innovations from companies across the digital health ecosystem.
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration. The selected 100 companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations.
View the full 2017 Digital Health 100 Award List at www.thejournalofmhealth.com